Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries

European Journal of Pharmacology

Volumn 521, Issue 1-3, 2005, Pages 124-132

  Persson, Anna Asplund ^a   Gunnarsson, Peter ^a   Lindström, Eva ^a   Grenegård, Magnus ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

cGMP; Dephostatin; GEA 3175; Nitric oxide; Protein phosphorylation; Relaxation; SNAP

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3 (3 CHLORO 2 METHYLPHENYL) 5 (4 METHYLBENZENESULFONYLIMINO) 1,2,3,4 OXATRIAZOLE; ACETYLCHOLINE; CYCLIC GMP; DEPHOSTATIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROSAMINE; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; ILIAC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWINE; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINE; ANIMALS; BLOTTING, WESTERN; CYCLIC GMP; ENZYME INHIBITORS; GUANYLATE CYCLASE; HYDROQUINONES; ILIAC ARTERY; NITRIC OXIDE; NITRIC OXIDE DONORS; OXADIAZOLES; PENICILLAMINE; PHENYLEPHRINE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; QUINOXALINES; SERINE; SIGNAL TRANSDUCTION; SWINE; TRIAZOLES; TYROSINE; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 26444538487     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.08.023     Document Type: Article

References (22)

1. H. Al-Sa'doni, A. Ferro, T. Munzel, S. Kurz, T. Heitzer, and D.G. Harrison S-nitrosothiols: a class of nitric oxide-donor drugs; New insights into mechanisms underlying nitrate tolerance Clin. Sci. (Lond). 98 2000 507 520
2. A.K. Asplund Persson, L. Palmér, P. Gunnarsson, and M. Grenegård Characterisation of GEA 3175 on human platelets; comparison with S-nitroso-N-acetyl-d, l-penicillamine Eur. J. Pharmacol. 496 2004 1 9
3. K.L. Axelsson, K.E. Bornefeldt, B. Norlander, and J.E. Wikberg Attomole sensitive radioimmunoassay for cyclic GMP Second Messengers Phosphoprot. 12 1988 145 154
4. J.A. Carvajal, A.M. Germain, J.P. Huidobro-Toro, and C.P. Weiner Molecular mechanism of cGMP-mediated smooth muscle relaxation J. Cell Physiol. 184 2000 409 420
5. M. Feelisch The use of nitric oxide donors in pharmacological studies Naunyn-Schmiedeberg's Arch. Pharmacol. 358 1998 113 122
6. A.D. Hughes, and S. Wijetunge Role of tyrosine phosphorylation in excitation-contraction coupling in vascular smooth muscle Acta. Physiol. Scand. 164 1998 457 469
7. M. Imoto, H. Kakeya, T. Sawa, C. Hayashi, M. Hamada, T. Takeuchi, and K. Umezawa Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by streptomyces, taxonomy, isolation, and characterization J. Antibiot. (Tokyo) 46 1993 1342 1346
8. I.G. Johansson Rydberg, R.G. Andersson, and M. Grenegård Effects of the nitric oxide-donor, GEA 3175, on guinea-pig airways Eur. J. Pharmacol. 329 1997 175 180
9. H. Kankaanranta, E. Rydell, A.S. Petersson, P. Holm, E. Moilanen, T. Corell, G. Karup, P. Vuorinen, S.B. Pedersen, A. Wennmalm, and T. Metsa-Ketela Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives Br. J. Pharmacol. 117 1996 401 406
10. A.I. Lajas, M.J. Pozo, P.J. Camello, G.M. Salido, J. Singh, and J.A. Pariente Effect of dephostatin on intracellular free calcium concentration and amylase secretion in isolated rat pancreatic acinar cells Mol. Cell. Biochem. 205 2000 163 169
11. K. Murphy, V. Gerzanich, H. Zhou, S. Ivanova, Y. Dong, G. Hoffman, G.A. West, H.R. Winn, and J.M. Simard Adenosine-A2a receptor down-regulates cerebral smooth muscle L-type Ca2+ channel activity via protein tyrosine phosphatase, not cAMP-dependent protein kinase Mol. Pharmacol. 64 2003 640 649
12. C. Napoli, and L.J. Ignarro Nitric oxide-releasing drugs Annu. Rev. Pharmacol. Toxicol. 43 2003 97 123
13. M. Reinhard, K. Jouvenal, D. Tripier, and U. Walter Identification, purification, and characterization of a zyxin-related protein that binds the focal adhesion and microfilament protein VASP (vasodilator-stimulated phosphoprotein) Proc. Natl. Acad. Sci. U. S. A. 92 1995 7956 7960
14. A. Schafer, M. Burkhardt, T. Vollkommer, J. Bauersachs, T. Munzel, U. Walter, and A. Smolenski Endothelium-dependent and independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta Biochem. Pharmacol. 65 2003 397 405
15. J. Schlossmann, R. Feil, and F. Hofmann Signaling through NO and cGMP-dependent protein kinases Ann. Med. 35 2003 21 27
16. A.P. Somlyo, and A.V. Somlyo Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase Physiol. Rev. 83 2003 1325 1358
17. A.K. Srivastava, and J. St-Louis Smooth muscle contractility and protein tyrosine phosphorylation Mol. Cell Biochem. 176 1997 47 51
18. T. Suzuki, A. Hiroki, T. Watanabe, T. Yamashita, I. Takei, and K. Umezawa Potentiation of insulin-related signal transduction by a novel protein-tyrosine phosphatase inhibitor, Et-3,4-dephostatin, on cultured 3T3-L1 adipocytes J. Biol. Chem. 276 2001 27511 27518
19. S. Wakino, U. Kintscher, Z. Liu, S. Kim, F. Yin, M. Ohba, T. Kuroki, A.H. Schonthal, W.A. Hsueh, and R.E. Law Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase C delta pathway in vascular smooth muscle cells J. Biol. Chem. 276 2001 47650 47657
20. S. Wijetunge, J.S. Lymn, and A.D. Hughes Effect of inhibition of tyrosine phosphatases on voltage-operated calcium channel currents in rabbit isolated ear artery cells Br. J. Pharmacol. 124 1998 307 316
21. T. Voets, V. Manolopoulos, J. Eggermont, C. Ellory, G. Droogmans, and B. Nilius Regulation of a swelling-activated chloride current in bovine endothelium by protein tyrosine phosphorylation and G proteins J. Physiol. 506 1998 341 352
22. Y. Zhang, and N. Hogg S-nitrosothiols: cellular formation and transport Free Radic. Bio. Med. 38 2005 831 838